EUTAW, Ala. — Leroy Walker arrived at the county hospital short of breath. Walker, 65 and with chronic high blood pressure, was brought in by one of rural Greene County’s two working ambulances. Nurses checked his heart activity with a portable electrocardiogram machine, took X-rays, and tucked him into Room 122 with an IV pump…
The Novo Nordisk/Ascendis partnership’s lead program is once-monthly injectable semaglutide for type 2 diabetes and obesity. This product candidate will be developed with Ascendis Pharma technology that has already yielded two FDA-approved products with longer dosing intervals. The post Novo Nordisk Commits $285M to Ascendis to Kick Off Alliance on Longer-Acting GLP-1 Drugs appeared first…
Funding from CDC has been a major source of support for public health programs across the U.S., but CDC is now being targeted for budget cuts by the Trump administration. To better understand how much CDC funding is provided to state and local jurisdictions, we analyzed FY 2023 funding data from CDC and present findings…
VP Harris appeared on ABC’s “The View” to outline the campaign’s new proposal for home healthcare
Lissy Hu, M.D., M.B.A., says greater personalization of the learning experience has benefits for the learner as well as the health system.
Former President Trump’s return to the White House in 2025 could bring big changes to health policy, especially with Republicans projected to control both chambers of Congress. To discuss the possible range of administrative to legislative actions, KFF held a virtual media availability for journalists on November 8, 2024, over Zoom. KFF experts were available…More
The Common Health Coalition’s Challenge on Community Health Workers is designed to advance meaningful CHW initiatives through partnerships between healthcare and public health
Ascentage Pharma’s U.S. IPO will support clinical testing of its two lead drugs, small molecules in development for advanced cases of certain blood cancers. Takeda holds an exclusive option to develop and commercialize one of those drugs in most of the world. The post Ascentage Has First U.S. Biotech IPO of 2025, Raising $126M to…
That is the title of a new paper with Shanshan Wang, Jaehong Kim, and Slaven Sikirica that has the subtitle “Budget impact analysis from the US payer perspective.” That abstract is below: BACKGROUND:Heart failure (HF) is a leading cause of mortality in the United States, often complicated by comorbidities like diabetes mellitus. These patients face…